The role of microparticles in inflammation and transfusion: A concise review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lacroix, 2013, Revisited role of microparticles in arterial and venous thrombosis, J Thromb Haemost, 11, 24, 10.1111/jth.12268
Jesel, 2013, Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity, Int J Cardiol, 168, 660, 10.1016/j.ijcard.2013.03.031
Morel, 2011, Cellular mechanisms underlying the formation of circulating microparticles, Arterioscler Thromb Vasc Biol, 31, 15, 10.1161/ATVBAHA.109.200956
Mause, 2010, Microparticles: protagonists of a novel communication network for intercellular information exchange, Circ Res, 107, 1047, 10.1161/CIRCRESAHA.110.226456
Goubran, 2015, Platelet microparticle: a sensitive physiological “fine tuning” balancing factor in health and disease, Transfus Apher Sci, 52, 12, 10.1016/j.transci.2014.12.015
Dengler, 2013, Neutrophil intercellular communication in acute lung injury. Emerging roles of microparticles and gap junctions, Am J Respir Cell Mol Biol, 49, 1, 10.1165/rcmb.2012-0472TR
Markiewicz, 2013, Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases, J Aging Res, 2013, 734509, 10.1155/2013/734509
van der Pol, 2013, Innovation in detection of microparticles and exosomes, J Thromb Haemost, 11, 36, 10.1111/jth.12254
Flaumenhaft, 2006, Formation and fate of platelet microparticles, Blood Cells Mol Dis, 36, 182, 10.1016/j.bcmd.2005.12.019
Wolfs, 2005, Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction, Cell Mol Life Sci, 62, 1514, 10.1007/s00018-005-5099-y
Enjeti, 2008, Microparticles in health and disease, Semin Thromb Hemost, 34, 683, 10.1055/s-0028-1104547
Hankins, 2015, Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution, Traffic, 16, 35, 10.1111/tra.12233
van der Mark, 2013, P4 ATPases: flippases in health and disease, Int J Mol Sci, 14, 7897, 10.3390/ijms14047897
van Meer, 2011, Dynamic transbilayer lipid asymmetry, Cold Spring Harb Perspect Biol, 3, 10.1101/cshperspect.a004671
Kodigepalli, 2015, Roles and regulation of phospholipid scramblases, FEBS Lett, 589, 3, 10.1016/j.febslet.2014.11.036
Van den Eijnde, 1997, Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis, Cell Death Differ, 4, 311, 10.1038/sj.cdd.4400241
Fabisiak, 2014, Quantification of selective phosphatidylserine oxidation during apoptosis, Methods Mol Biol, 1105, 603, 10.1007/978-1-62703-739-6_41
Gillies, 2014, Apoptosis regulation at the mitochondrial outer membrane, J Cell Biochem, 115, 632, 10.1002/jcb.24709
Czabotar, 2014, Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy, Nat Rev Mol Cell Biol, 15, 49, 10.1038/nrm3722
Horstman, 1999, Platelet microparticles: a wide-angle perspective, Crit Rev Oncol Hematol, 30, 111, 10.1016/S1040-8428(98)00044-4
Bode, 1991, Vesiculation of platelets during in vitro aging, Blood, 77, 887, 10.1182/blood.V77.4.887.887
Burnouf, 2015, An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful ?, Transfus Apher Sci, 53, 137, 10.1016/j.transci.2015.10.010
Solum, 1999, Procoagulant expression in platelets and defects leading to clinical disorders, Arterioscler Thromb Vasc Biol, 19, 2841, 10.1161/01.ATV.19.12.2841
Chironi, 2006, Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects, Arterioscler Thromb Vasc Biol, 26, 2775, 10.1161/01.ATV.0000249639.36915.04
Tan, 2005, The potential role of platelet microparticles in atherosclerosis, Thromb Haemost, 94, 488, 10.1160/TH05-03-0201
Brogan, 2004, Endothelial and platelet microparticles in vasculitis of the young, Arthritis Rheum, 50, 927, 10.1002/art.20199
Kambas, 2014, Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease, Ann Rheum Dis, 73, 1854, 10.1016/j.transci.2015.10.012
Thaler, 2012, Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients, J Thromb Haemost, 10, 1363, 10.1111/j.1538-7836.2012.04754.x
Chirinos, 2005, Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism, J Am Coll Cardiol, 45, 1467, 10.1016/j.jacc.2004.12.075
Mallat, 2000, Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes, Circulation, 101, 841, 10.1161/01.CIR.101.8.841
Montoro-Garcia, 2013, Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes, Atherosclerosis, 227, 313, 10.1016/j.atherosclerosis.2013.01.028
Sinning, 2011, Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes, Eur Heart J, 32, 2034, 10.1093/eurheartj/ehq478
Nozaki, 2009, Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease, J Am Coll Cardiol, 54, 601, 10.1016/j.jacc.2009.05.022
Tramontano, 2010, Circulating endothelial microparticles in diabetes mellitus, Mediators Inflamm, 2010, 250476, 10.1155/2010/250476
Nomura, 2009, Dynamic role of microparticles in type 2 diabetes mellitus, Curr Diabetes Rev, 5, 245, 10.2174/157339909789804404
Stepanian, 2013, Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss, Obesity (Silver Spring), 21, 2236, 10.1002/oby.20365
Agouni, 2008, Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome, Am J Pathol, 173, 1210, 10.2353/ajpath.2008.080228
Amabile, 2014, Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study, Eur Heart J, 35, 2972, 10.1093/eurheartj/ehu153
Zahra, 2011, Microparticles, malignancy and thrombosis, Br J Haematol, 152, 688, 10.1111/j.1365-2141.2010.08452.x
Zwicker, 2009, Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy, Clin Cancer Res, 15, 6830, 10.1158/1078-0432.CCR-09-0371
Marcos-Ramiro, 2014, Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function, BMC Neurosci, 15, 110, 10.1186/1471-2202-15-110
Saenz-Cuesta, 2014, Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis, Biomark Med, 8, 653, 10.2217/bmm.14.9
Boilard, 2010, Platelets amplify inflammation in arthritis via collagen-dependent microparticle production, Science, 327, 580, 10.1126/science.1181928
Knijff-Dutmer, 2002, Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis, Arthritis Rheum, 46, 1498, 10.1002/art.10312
Ostergaard, 2013, Unique protein signature of circulating microparticles in systemic lupus erythematosus, Arthritis Rheum, 65, 2680, 10.1002/art.38065
Nielsen, 2012, Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation, Arthritis Rheum, 64, 1227, 10.1002/art.34381
Breen, 2014, Endothelial and platelet microparticles in patients with antiphospholipid antibodies, Thromb Res, 135, 368, 10.1016/j.thromres.2014.11.027
Chaturvedi, 2015, Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations, Thromb Res, 135, 102, 10.1016/j.thromres.2014.11.011
Kozuma, 2011, Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria, Br J Haematol, 152, 631, 10.1111/j.1365-2141.2010.08505.x
Simak, 2004, Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria, Br J Haematol, 125, 804, 10.1111/j.1365-2141.2004.04974.x
Mullier, 2014, Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis, Thromb Res, 133, 1068, 10.1016/j.thromres.2013.12.009
Kasthuri, 2012, PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcgammaRI, Blood, 119, 5285, 10.1182/blood-2011-06-359430
Sewify, 2013, Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura, Thromb Res, 131, e59, 10.1016/j.thromres.2012.11.021
Jimenez, 2003, Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation, Br J Haematol, 123, 896, 10.1046/j.1365-2141.2003.04716.x
Tantawy, 2013, Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications, Platelets, 24, 605, 10.3109/09537104.2012.749397
van Beers, 2009, Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease, Haematologica, 94, 1513, 10.3324/haematol.2009.008938
El-Assaad, 2014, Production, fate and pathogenicity of plasma microparticles in murine cerebral malaria, PLoS Pathog, 10, e1003839, 10.1371/journal.ppat.1003839
Nieuwland, 2000, Cellular origin and procoagulant properties of microparticles in meningococcal sepsis, Blood, 95, 930, 10.1182/blood.V95.3.930.003k46_930_935
Frleta, 2012, HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44, J Clin Invest, 122, 4685, 10.1172/JCI64439
Baker, 2013, Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients, J Acquir Immune Defic Syndr, 63, 367, 10.1097/QAI.0b013e3182910121
Stadnicki, 2013, Thrombin generation and microparticles in inflammatory bowel diseases, J Pediatr Gastroenterol Nutr, 56, 343, 10.1097/MPG.0b013e31827daf94
Leonetti, 2013, Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions, PLoS ONE, 8, e73088, 10.1371/journal.pone.0073088
Choi, 2014, Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury, PLoS ONE, 9, e87853, 10.1371/journal.pone.0087853
Gao, 2012, Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome, Thromb Haemost, 107, 681, 10.1160/TH11-09-0673
Amabile, 2005, Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure, J Am Soc Nephrol, 16, 3381, 10.1681/ASN.2005050535
Wiedmer, 1990, Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor, Biochemistry, 29, 623, 10.1021/bi00455a005
Iwamoto, 1997, The release mechanism of platelet-activating factor during shear-stress induced platelet aggregation, Biochem Biophys Res Commun, 239, 101, 10.1006/bbrc.1997.7435
Diamant, 2004, Cellular microparticles: new players in the field of vascular disease?, Eur J Clin Invest, 34, 392, 10.1111/j.1365-2362.2004.01355.x
Prudent, 2015, Differences between stimulated and natural erythrocytes-derived microvesicles, Transfus Apher Sci, 53, 153, 10.1016/j.transci.2015.10.012
Liu, 2014, Mechanism of faster NO scavenging by older stored red blood cells, Redox Biol, 2, 211, 10.1016/j.redox.2013.12.014
Satta, 1994, Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide, J Immunol, 153, 3245, 10.4049/jimmunol.153.7.3245
Mesri, 1999, Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway, J Biol Chem, 274, 23111, 10.1074/jbc.274.33.23111
Osmanovic, 2000, Soluble selectins in sepsis: microparticle-associated, but only to a minor degree, Thromb Haemost, 84, 731, 10.1055/s-0037-1614100
Shet, 2008, Characterizing blood microparticles: technical aspects and challenges, Vasc Health Risk Manag, 4, 769, 10.2147/VHRM.S955
Sabatier, 2002, Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity, Blood, 99, 3962, 10.1182/blood.V99.11.3962
Schiro, 2014, Endothelial microparticles as conveyors of information in atherosclerotic disease, Atherosclerosis, 234, 295, 10.1016/j.atherosclerosis.2014.03.019
Helbing, 2014, Role of microparticles in endothelial dysfunction and arterial hypertension, World J Cardiol, 6, 1135, 10.4330/wjc.v6.i11.1135
Nurden, 2011, Platelets, inflammation and tissue regeneration, Thromb Haemost, 105, S13, 10.1160/THS10-11-0720
Cloutier, 2013, The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes, EMBO Mol Med, 5, 235, 10.1002/emmm.201201846
Daniel, 2006, Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis, Kidney Int, 69, 1416, 10.1038/sj.ki.5000306
Fourcade, 1995, Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells, Cell, 80, 919, 10.1016/0092-8674(95)90295-3
Barry, 1999, Mechanisms of cellular activation by platelet microparticles, Thromb Haemost, 82, 794, 10.1055/s-0037-1615913
Barry, 1999, Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway, J Biol Chem, 274, 7545, 10.1074/jbc.274.11.7545
Barry, 1997, Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles, J Clin Invest, 99, 2118, 10.1172/JCI119385
Xie, 2015, Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells, Transfusion, 55, 1051, 10.1111/trf.12952
Zibara, 2000, Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice, Arterioscler Thromb Vasc Biol, 20, 2288, 10.1161/01.ATV.20.10.2288
Barry, 1998, Modulation of monocyte-endothelial cell interactions by platelet microparticles, J Clin Invest, 102, 136, 10.1172/JCI2592
Nomura, 2000, Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines, Thromb Res, 98, 257, 10.1016/S0049-3848(00)00186-9
Forlow, 2000, Leukocyte-leukocyte interactions mediated by platelet microparticles under flow, Blood, 95, 1317, 10.1182/blood.V95.4.1317.004k30_1317_1323
Osumi, 2001, Development and assessment of enzyme immunoassay for platelet-derived microparticles, Thromb Haemost, 85, 326, 10.1055/s-0037-1615688
George, 2008, Microparticles in vascular diseases, Thromb Res, 122, S55, 10.1016/S0049-3848(08)70020-3
Gasser, 2004, Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis, Blood, 104, 2543, 10.1182/blood-2004-01-0361
Koppler, 2006, Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory propertiesof microparticles, Eur J Immunol, 36, 648, 10.1002/eji.200535435
Kent, 2014, The pro-inflammatory potential of microparticles in red blood cell units, Transfus Med, 24, 176, 10.1111/tme.12123
Wolf, 1967, The nature and significance of platelet products in human plasma, Br J Haematol, 13, 269, 10.1111/j.1365-2141.1967.tb08741.x
Burnouf, 2014, Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine, Blood Rev, 28, 155, 10.1016/j.blre.2014.04.002
Blair, 2009, Platelet alpha-granules: basic biology and clinical correlates, Blood Rev, 23, 177, 10.1016/j.blre.2009.04.001
Flaumenhaft, 2010, Platelet- and megakaryocyte-derived microparticles, Semin Thromb Hemost, 36, 881, 10.1055/s-0030-1267042
Rubin, 2008, Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools, Vox Sang, 95, 288, 10.1111/j.1423-0410.2008.01101.x
Curvers, 2004, Decreased responsiveness and development of activation markers of PLTs stored in plasma, Transfusion, 44, 49, 10.1111/j.0041-1132.2004.00628.x
Bode, 1994, Effect of cold storage on platelet glycoprotein Ib and vesiculation, Transfusion, 34, 690, 10.1046/j.1537-2995.1994.34894353465.x
Boing, 2008, Platelet microparticles contain active caspase 3, Platelets, 19, 96, 10.1080/09537100701777295
Matijevic, 2011, Multiple levels of degradation diminish hemostatic potential of thawed plasma, J Trauma, 70, 71, 10.1097/TA.0b013e318207abec
Sinauridze, 2007, Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets, Thromb Haemost, 97, 425, 10.1160/TH06-06-0313
Lawrie, 2008, The dynamics of clot formation in fresh-frozen plasma, Vox Sang, 94, 306, 10.1111/j.1423-0410.2008.01037.x
Berckmans, 2001, Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation, Thromb Haemost, 85, 639, 10.1055/s-0037-1615646
Phipps, 2001, Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion, Lancet, 357, 2023, 10.1016/S0140-6736(00)05108-4
Elzey, 2011, Platelet CD40L at the interface of adaptive immunity, Thromb Res, 127, 180, 10.1016/j.thromres.2010.10.011
Blumberg, 2006, An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions, Transfusion, 46, 1813, 10.1111/j.1537-2995.2006.00979.x
Sahler, 2012, CD40 ligand (CD154) involvement in platelet transfusion reactions, Transfus Clin Biol, 19, 98, 10.1016/j.tracli.2012.02.003
Sandgren, 2014, Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES, Transfusion, 54, 602, 10.1111/trf.12345
Cognasse, 2006, Release of potential immunomodulatory factors during platelet storage, Transfusion, 46, 1184, 10.1111/j.1537-2995.2006.00869.x
Hamzeh-Cognasse, 2014, Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions, Transfusion, 54, 613, 10.1111/trf.12378
Aloui, 2014, The signaling role of CD40 ligand in platelet biology and in platelet component transfusion, Int J Mol Sci, 15, 22342, 10.3390/ijms151222342
Aloui, 2014, Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?, Sci Rep, 4, 7239, 10.1038/srep07239
Krailadsiri, 2000, Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets, Vox Sang, 78, 171, 10.1046/j.1423-0410.2000.7830171.x
Thon, 2008, Platelet storage lesion: a new understanding from a proteomic perspective, Transfus Med Rev, 22, 268, 10.1016/j.tmrv.2008.05.004
Schubert, 2010, Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality, J Proteomics, 73, 436, 10.1016/j.jprot.2009.08.002
Krailadsiri, 2006, The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components, Transfusion, 46, 407, 10.1111/j.1537-2995.2006.00737.x
Poncelet, 2015, Tips and tricks for flow cytometry-based analysis and counting of microparticles, Transfus Apher Sci, 53, 110, 10.1016/j.transci.2015.10.008